Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_provenance.
- NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_assertion description "[The Seipin/BSCL2 gene was originally identified as a loss-of-function gene for congenital generalized lipodystrophy type 2 (CGL2), a condition characterized by severe lipoatrophy, insulin resistance, hypertriglyceridaemia and mental retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_provenance.
- NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_assertion evidence source_evidence_literature NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_provenance.
- NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_assertion SIO_000772 18790819 NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_provenance.
- NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_assertion wasDerivedFrom befree-20150227 NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_provenance.
- NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_assertion wasGeneratedBy ECO_0000203 NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_provenance.
- befree-20150227 importedOn "2015-02-27" NP511317.RAay9GUJk0kp_KzveyXtj6_ABN32a8VGsWJvvmeji8dN8130_provenance.